Loading...
Loading...
Shasha, the founder of Sassy Options discussed high priced stocks that have a lot of movement, specifically,
Intercept Pharmaceuticals Inc.ICPT She said that she had already purchased January 2016 calls which have worked out "beautifully" thus far.
Shasha added that the investment idea is still a buy-idea despite some "healthy" consolidation seen in shares recently. She added that it is often difficult to invest in weekly, bi-weekly and monthly options given expected volatility but over a full year shares are expected to go "much higher."
She finally argued that Intercept is one of the only companies that hold the potential to produce meaningful therapies among patients suffering from liver issues which represents a large market.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in